Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant

Clinical trial NCT01790568 · COMPLETED

Trial details

NCT number: NCT01790568
Sponsor: University of Michigan Rogel Cancer Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Graft vs Host Disease Hematologic Neoplasms Non-Neoplastic Hematologic and Lymphocytic Disorder

Start date: 2014-12-01
Primary completion: 2017-01-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.